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Increasing donor age is associated with reduced graft
function. We wondered if donor age may not only affect
intrinsic function but also alter the immune response of the
recipient. Kidneys from young and old F-344 rats (3 vs 18
months) were transplanted into bilaterally nephrectomized
young Lewis recipients and compared with age-matched
controls (follow-up: 6 months). Renal function and structural
changes were assessed serially in both native kidneys and
allografts. Host alloreactivity, graft-infiltrating cells, and their
inflammatory products were determined at intervals to
examine the correlation of immune response and donor age.
Functional and structural deterioration had advanced
significantly in older allografts compared with age-matched
native controls, whereas differences between young
allografts and native controls of similar age were only minor.
Changes in grafts from elderly rats were associated with a
more intense host immune response early post-transplant
(up to 1 month) reflected by significantly higher numbers of
peripheral T and B cells, increased T-cell alloreactivity and
modified cytokine patterns associated with elevated
frequencies of intragraft dendritic cells, B cells, and CD31þ
cells. By 6 months, recipients of young donor grafts produced
comparable or more intense alloantigen-specific immune
responses. Older donor grafts elicit a stronger immune
response in the early period after transplantation.
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The growing organ shortage represents the largest problem in
organ transplantation. As a consequence, increased numbers of
so-called ‘marginal’ or extended criteria donor grafts are
utilized. Although a common and broadly accepted definition
for the term extended criteria donor has not been coined,
various donor criteria, including comorbid disease, intensive
care treatment, brain death, organ harvesting, and prolonged
ischemia have been identified as relevant risk factors.
Additionally, increased donor and recipient age have been
shown as independent risk factors for the development of
chronic graft dysfunction in clinical and experimental studies.1
Studies in the European-Senior-Program (ESP) suggested
that age matching of donor and recipient may have a
beneficial effect on graft outcome. The engraftment of
kidneys from older donors into elderly recipients with an
ameliorated immune response may allow physiological
matching.2–4 However, our initial clinical experience with
grafts from elderly donor grafts and recipients with less
potent, calcineurin-inhibitor (CNI)-free immunosuppression
demonstrated increased rates of acute rejection episodes
requiring frequent conversion to more potent immunosup-
pressants.5
Our own previous experimental data revealed an accele-
ration of chronic graft dysfunction with increasing donor and
recipient age.6 These results may be dependent on a modified
immune response in older recipients, particularly during the
early post-transplant period. On the other hand, grafts from
older donors may elicit an accelerated immune response due
to elevated immunogenicity and reduced resistance to
unspecific damages.
An increased incidence of acute rejection episodes
associated with transplantation of older donor grafts may
influence long-term function.7–9 In addition, a reduced
capability for repair and renewal of damaged tissue may
result in a persistent inflammation in parallel to increased
antigen recognition.10–13 Moreover, several clinical and
experimental studies demonstrated an increased allostimula-
tion by ‘aged’ antigen-presenting cells (APC) and enhanced
immune responses following the contact with aged APC.14,15
In the current study, we dissected the effects of donor age
on graft immunogenicity and consecutive alterations of the
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recipient’s immune response in an established experimental
kidney transplantation model.
RESULTS
Recipients of grafts from both young and old donors survived
the observation period. To correlate age-related physiological
changes with alterations in age-matched allografts, we
measured the increment of functional/structural deterioration.
Renal function
Proteinuria in old native uni-nephrectomized controls
increased twofold over the 6 months observation period,
while rising almost fivefold during this time period in older
allografts (increase: P¼ 0.0003; old vs young allograft by
month 6: P¼ 0.0015; Figure 1, Table 1). In contrast,
proteinuria remained stable in both, young native controls
and recipients of young donor grafts (P¼NS).
Creatinine clearance (CL) was significantly lower in
recipients of older donor grafts at the end of the observation
period (P¼ 0.0093), whereas no significant differences were
observed between young and old nephrectomized controls
(Table 1).
Morphology
Morphological criteria were not significantly different
between 3- and 18-month-old native controls. However, the
ratio of structural changes had significantly progressed in
older donor grafts/older age-matched native controls vs
younger donor grafts/younger age-matched controls (Figure
2a–d, Table 1).
Alloantigen-specific intracellular IFN-c secretion
enzyme-linked immunosorbent assay
The immune response of recipients of elderly donor grafts
was more intense than that of recipients of younger donor
grafts. Although levels of intracellular interferon (IFN)-g
increased during the observation period in both recipients of
young and old donors, grafts from older donors elicited
higher frequencies of alloreactive T cells (P¼ 0.0022 by
month 1, and P¼ 0.04 by month 3, respectively; Figure 3).
Cytokine production after in vitro stimulation of splenocytes
ELISA
Production of interleukin (IL)-2, IFN-g, IL-4, and IL-10 was
significantly elevated in recipients of old donor grafts early
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Figure 1 | Urinary protein secretion (mg/24 h) in young LEW
recipients following the transplantation (Tx) of young or old
F-344 donor kidneys. Age-matched nephrectomized (Nx) animals
served as controls. While proteinuria in old vs young native
age-matched nephrectomized controls increased twofold from
month 1 to 6, proteinuria in recipients of old donor kidneys increased
almost fivefold during this time period compared with recipients of
young donor organs.
Table 1 | Renal function (proteinuria, creatinine clearance) and structural changes (glomerulosclerosis, arteriosclerosis, tubular
atrophy, fibrosis, cellular infiltration) following the transplantation (Tx) of young or old F-344 donor kidneys into young Lewis
recipients compared to age-matched nephrectomized (Nx) control animals
Renal function and structural
Nx: control age Tx: donor age
changes 6 months post-Nx/Tx 3 months vs 18 months 3 months vs 18 months
Urinary protein (mg/24 h)
1 month post-Nx/Tx
7.570.7. NS 12.874.4
(NS vs 6 months)
9.370.8 P=0.0421 13.971.2 (P=0.0003
vs 6 months)
Urinary protein (mg/24 h)
6 month post-Nx/Tx
7.970.5 P=0.0159 26.374.1 7.070.9 P=0.0015 66.679.4 (P=0.0107
vs Nx control)
Creatinine clearance (ml/min) 1.9670.20 NS 1.7270.42 1.9870.19 P=0.0093 1.2570.14
Glomerulosclerosis (%) 2073 NS 36714 2674 P=0.0317 5278
Arteriosclerosisa 1.970.1 NS 2.070.1 2.170.1 NS 2.370.2
Tubulary atrophya 1.770.2 NS 1.570.5 1.470.2 P=0.0061 2.570.2 (P=0.0195
vs Nx control)
Fibrosisa 1.070.3. NS 0.770.3 0.370.2 P=0.0075 1.970.4 (P=0.072
vs Nx control)
Cellular infiltrationa 1.070.2 NS 1.570.3 0.670.2 P=0.0004 2.570.2 (P=0.0429
vs Nx control)
NS, nonsignificant; Nx, nephrectomy; Tx, transplantation.
aThe extent of arteriosclerosis, tubular atrophy, interstitial fibrosis, and cellular infiltrates was quantified on a 0 to 4+ scale (4+=greatest structural deterioration / 420 fields of
view (fv) per section were evaluated at  200).
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after transplantation (by 1 month: IL-2: Po0.0001;. IFN-g:
Po0.0001; IL-4: P¼ 0.0027; IL-10: Po0.0001). However, at
the end of the observation period levels for IFN-g and IL-4
had increased in recipients of young donor grafts (IFN-g:
P¼ 0.0128; IL-4: P¼ 0.0045; Figure 4).
T-cell subsets, B cells, and DC in peripheral organs
Recipients of older donor grafts displayed significantly
increased amounts of CD3þCD4þ T cells in spleens early
after transplantation (P¼ 0.028 and 0.017 by days 5 and 10,
respectively). In parallel, CD3þCD8þ cells had increased in
peripheral blood and spleens in recipients of elderly donor
grafts (P¼ 0.0012 and 0.0535, respectively, by day 3; data not
shown). Peripheral blood immunoglobulin (Ig)kþ B cells
had significantly increased in recipients of older donor grafts
at early time intervals (P¼ 0.0001 by day 5, and P¼ 0.0049
by 1 month, respectively; Figure 5). By 6 months, however,
frequencies of T and B cells were comparable in all
compartments. The presence of dendritic cells (DC) in
peripheral compartments (spleen, lymph nodes, blood) was
not influenced by donor age at any time.
Graft-infiltrating cells
Intragraft OX62þ DC were elevated in recipients of elderly
grafts at early time intervals (P¼ 0.011 and 0.016 by day 3
and 1 month, respectively). At later time intervals (3 and 6
months) frequencies of intragraft DC were not different in
young and old donor transplants (Figure 6).
The majority of graft-infiltrating cells expressing high
levels of major histocompatibility complex (MHC) class II
and the costimulatory molecule CD86 were found within the
Igkþ B-cell population. These cells were significantly
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Figure 2 | Structural changes 6 months post-nephrectomy/
transplantation (Nx/Tx). (a) Nx control/3 months old at time of Nx,
(b) Nx control/18 months old at time of Nx, (c) Tx/donor age 3
months, and (d) Tx/donor age 18 months. Structural changes had
significantly progressed in older grafts after 6 months (representative
graft sections following hematoxylin and eosin staining, original
magnification  200).
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Figure 3 | T cell alloreactivity. Secretion of intracellular IFN-g
following donor-specific in vitro stimulation of recipient splenocytes
(ELISPOT). Although levels of intracellular IFN-g increased during the
observation period in both, recipients of young and old donors, older
grafts elicited higher frequencies of alloreactive T cells at all time
intervals.
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Figure 4 | Serial analysis of cytokine production following in vitro
stimulation of recipient splenocytes (enzyme-linked
immunosorbent assay). Production of IL-2, IFN-g, IL-4, and IL-10
increased significantly in recipients of old grafts 1 month post-Tx.
In contrast, after 6 months levels of IFN-g and IL-4 had increased in
recipients of grafts from young donors, whereas the production of
IL-2 and IL-10 was comparable in both study groups at the end of
the observation period.
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increased in grafts from older donors (Igkþ B cells,
P¼ 0.001 and 0.065; Igkþ MHC class IIþ cells, P¼ 0.035
and 0.063; Igkþ CD86þ cells, P¼ 0.009 and 0.022, by days
3 and 5, respectively; Figure 7a–c). Intragraft B cells peaked by
day 10 in both, recipients of young and old donor grafts,
albeit not showing quantitative significant differences at that
time, and declined significantly at later time intervals
(Po0.05). The endothelial marker platelet-endothelial cell
adhesion molecule (PECAM)-1 (CD31) was significantly
higher expressed in older donor grafts early after transplanta-
tion (CD31þ cells, P¼ 0.0016, and CD31þ MHC class IIþ
cells, P¼ 0.0008 by day 3, not shown).
Thus, overall graft-infiltrating cells and activation markers
were more pronounced early after transplantation in kidneys
from older donors, whereas stronger in younger donor
kidneys at later time intervals.
DISCUSSION
Donor age is an important predictor of long-term graft
outcome.10,16,17 Grafts from older donors demonstrate an
increased incidence of acute rejection episodes in the early
post-transplantation period7–9,18 leading to subsequent
chronic graft deterioration. Pre-existing donor criteria such
as age, previous diseases, and brain death as well as
perioperative injuries may influence long-term graft survival
in an antigen-independent, nonspecific manner.19
The aging process causes important changes that result in
a diminution of the functional reserve and inability to
respond adequately to stress conditions.10,20 Recently,
Halloran et al.10 introduced the term ‘senescence’, a normal
process in the cell cycle to sort out exhausted cells and
prevent malignant mutations. Recent studies on cell biology,
aging, and senescence described the limitation of cell cycles of
somatic cells and telomere shortening with age in humans.
These processes, which finally lead to the shut down of the
cell, may play an important role in cellular senescence and
may explain the incompetence of aged organs to repair
damaged tissue.10,11 Indeed, grafts from older donors show
an impaired ability to repair injured tissue, which in turn
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Figure 5 | Fluorescence-activated cell sorter analysis of recipient
peripheral blood mononuclear cells. Cells were stained with
fluorescein isothiocyanate-conjugated mAb OX-12 specific for rat
Igkþ B cells. Recipients of older grafts demonstrated significantly
higher frequencies of peripheral blood B cells at early time intervals.
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Figure 6 | Serial fluorescence-activated cell sorter analysis
of intragraft DC. Cells were stained with fluorescein
isothiocyanate-conjugated mAb OX-62 specific for rat DC.
Intragraft OX62þ DC were significantly elevated in recipients
of older grafts early post-transplantation.
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Figure 7 | Serial fluorescence-activated cell sorter analysis of graft-infiltrating cells. (a–c) Cells were stained with conjugated mAbs
specific for Igkþ B cells, CD86, and MHC class II. Old grafts demonstrated significantly increased frequencies of intragraft B cells expressing
high levels of MHC class II and costimulatory molecule CD86 at early time intervals.
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may lead to persisting inflammation and increased immune
recognition. Previously, Melk et al.21 described mechanisms
of cell senescence in aged rat kidneys independent of
telomere shortening, which may contribute to nephron
shutdown and an age-related pathology of rat kidneys. In
keeping with the observation that immunosenescence and
many conditions leading to end stage renal disease share
common features of functional and structural decline, age-
related progressive fibrosis of both interstitium and glomeruli
may lead to enhanced infiltration of immune cells, thereby
promoting a proinflammatory environment.10,22 Besides,
primarily cortical loss of functional nephrons and increased
vascular resistance might further contribute to hyperfiltration
and proteinuria, which in turn lead to tubular cell activation,
gene expression of inflammatory mediators, and ongoing
immune response in aged kidneys. Accordingly, 18-month-
old rats displayed an almost normal GFR followed by a
continuously regressive filtration rate and total loss of
functional reserve beyond this age.23
Thus, it can be hypothesized that immunosenescence and
functional alterations with advancing age act synergistically
in stimulating unspecific inflammation, progressive func-
tional loss, and immune recognition. In regard to the ‘injury
response’, antigens expressed on injured grafts are more likely
to activate and provoke an immune response.9 This process is
associated with increased expression of proinflammatory
cytokines, MHC antigens, and increased recruitment and
activation of APC.12,13 Several clinical and experimental
studies report on an increased allostimulation by aged APC
and enhanced immune responses following the contact with
‘aged’ APC.14,15 DC are the most potent stimulators of T cells
and are responsible for initiating an immune response by
alloantigen presentation to naive T cells. Several authors
previously reported an impaired production of IL-1 by
peritoneal APC,24 altered levels of macrophage products,25
and dysregulation of macrophage-derived IL-12, IL-10, and
IFN-g production with increasing age.26,27 In addition, an
age-related impaired T-cell proliferation associated with
enhanced APC function and increased production of IL-10
and IL-12 has been reported.15,28
Chronic allograft deterioration is a multi-faceted process.
The F-344 – Lewis (LEW) kidney transplant model has been
used before by us and others to study the events of this
process.29,30 This model has been characterized with
differences in two MHC class I loci and various non-MHC
genes. An initial immunosuppression is necessary in this
model to suppress early acute rejection episodes. However,
long-term immunosuppression is not applied, thus differing
from the clinical situation.
Our experimental data demonstrate the induction of a
strong immune response in the early post-transplantation
period after engraftment of aged donor kidneys leading to
long-term functional and structural deterioration. While a
restricted physiological capacity of older grafts has been
assumed, we were able to show a modified immune response
with increasing donor age.
Although early functional measurements were not
obtained in our current experiment, donor age did not
impact early renal function (by 2 weeks) in a previous
study.19 Thus, senescence rather than consequences of
unspecific injuries associated with ischemia or delayed graft
function (DGF)31,32 seems to be causative for the modified
immune response observed in our model.
Alloreactive T cells increased during the observation
period in both recipients of young and old donor grafts.
However, T-cell alloreactivity was significantly elevated in
young recipients of old grafts after allospecific in vitro
stimulation with splenocytes of donor origin. Recipients of
older donor grafts demonstrated increased levels of IL-2,
IFN-g, IL-4, and IL-10 early after transplantation. At the end
of the observation period, levels were comparable (IL-2,
IL-10) or showed a significant increase (IFN-g, IL-4) in
recipients of young grafts at this time. T cell (CD3, CD4,
CD8) and Igkþ B cell counts were significantly elevated in
peripheral compartments early post-transplantation when
kidneys from older donors were engrafted accompanied by
higher frequencies of intragraft OX62þ DC. Again, those
differences declined by the end of the observation period.
Furthermore, we observed a strong intragraft B-cell
accumulation in older grafts early after transplantation with
a strong expression of MHC class II, the costimulatory
molecule CD86, and high frequencies of intragraft CD31þ
MHC class IIþ cells.
These effects may be related to an age-associated increase
in graft immunogenicity.
Thus, further investigations have to focus on the mode of
antigen presentation and the role of ‘passenger leukocytes’
within the ‘old’ graft potentially provoking a subsequent
stronger T-cell immune response in the young recipient.
Recognition of foreign antigens can occur by two distinct,
but not exclusive pathways. The direct pathway represents the
recognition of foreign MHC molecules on the surface of
donor APC. The indirect pathway occurs when donor MHC
molecules are internalized, processed, and presented to
alloreactive T cells by host APC.33 There is evidence that
donor DC (‘passenger leukocytes’) promote graft acceptance
by the indirect pathway. On the other hand, donor DC were
suggested to increase graft immunogenicity and to trigger
acute rejection by the direct pathway.34 The primary
presentation of donor antigen by the direct pathway in
combination with ‘aged’ donor-derived APC may lead to an
enhanced immune response, particular during the early
period after transplantation. It can be speculated that donor-
derived APC will be depleted from the transplanted organ
within weeks after transplantation, whereas recipient APC
permanently migrate through the graft.
In fact, our own results demonstrated an increase in T-cell
alloreactivity, cytokine production and higher numbers of
peripheral T and B cells early after transplantation in
recipients of older grafts, whereas differences in the immune
response to young vs old grafts were diminished at later time
points.
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An interesting finding in our study was the presence of an
increased B-cell infiltration in grafts from older donors.
Recent clinical studies described dense clusters of B cells in
kidney graft biopsies strongly associated with both severity
and steroid resistance of rejection episodes, suggesting an
important role of infiltrating B cells in acute rejection and
graft outcome.35,36 Moreover, a recent case report presented
data on acute rejection episodes with increased frequencies of
CD20þ B cell infiltrates refractory to standard immuno-
suppressive therapy. Consequently, graft function had
improved after treatment with rituximab, a humanized
anti-CD20 monoclonal antibody (mAb).37,38 B-cell infiltra-
tion was not correlated with humoral-mediated graft injury
as elevated levels of Ig or complement deposits were absent.35
Recent studies by Steinmetz et al.39 propose that CXCL13-
mediated attraction of CXCR5-expressing B cells into
rejecting allografts play a crucial role in B-cell cluster
formation and predict chronic allograft rejection. However,
the functional relevance of intragraft B cells needs further
investigation. Besides the production of alloantibodies, B cells
may play a pivotal role as APC in indirect antigen
recognition.
An additional finding in our studies was the high
intragraft frequency of CD31þ MHC class IIþ cells shortly
after transplantation of aged grafts in young recipients. The
CD31 mAb stains for the PECAM-1, which is expressed by
endothelial cells, platelets, monocytes, neutrophils, and
certain T-cell subsets and is involved in acute and chronic
allograft rejection via its effects on leukocyte trafficking.40–42
MHC class II molecules are upregulated on endothelial cells
in allografts. Interaction between alloreactive CD4þ T cells
and activated endothelial cells expressing MHC class II may
play a role in recruitment of leukocytes into vascularized
allografts and may provide antigen-dependent signals
through the direct pathway.42–44 Indeed, increased intragraft
PECAM-1 (CD31) and MHC class II expression in older
grafts was associated with enhanced leukocyte infiltration
(T cells, B cells, and DC) in our experiments. Although pre-
vious studies showed an increased expression of PECAM-1
on monocytes and leukocyte function-associated molecule-1
(CD11a) on lymphocytes with increasing age,45 others report
on age-related declines in numbers of blood mononuclear
and vascular endothelial cells, structural and functional
alterations, and a senescence-associated decline of lympho-
cyte migration.46–48
In conclusion, our results suggest that grafts from older
donors are more immunogenic and therefore recipients of
aged kidneys may require a more intense immunosuppres-
sion in the early period after transplantation. Donor
treatment may be particularly beneficial in older grafts.
MATERIALS AND METHODS
The transplantation model
Male inbred rats (Harlan Winkelmann, Borchen, Germany) were
used throughout the experiments. Kidneys from young and old
Fischer 344 rats (F-344, RT11v1, 3-month-old, 235730 g, and
18-month-old, 430730 g, respectively) were transplanted into LEW
recipients (RT11, 3-month-old, 275740 g) using standard micro-
surgical techniques (anastomosis time 2575 min). One native
kidney was removed during transplantation, and the remaining
kidney 10 days later; cyclosporine A treatment was given for 10 days
at a dosage of 1.5 mg/kg/day to prevent initial acute rejection
episodes. Before organ harvesting, grafts were perfused with
University of Wisconsin solution and kept at 41C for 5 min. Graft
survival and renal function (urinary protein excretion, creatinine
clearance) were monitored for 6 months. Data were compared with
native, uni-nephrectomized young and old controls to distinguish
age-related physiological changes at the beginning (3 and 18
months) and at the end of the observation period (9 and 24
months), respectively. Donor age-related immune response was
analyzed sequentially in graft sections, blood samples, and spleen of
allograft recipients taken by 3, 5, 10 days and 1, 3, and 6 months
(n¼ 6/group).
All animal experiments were performed with the permission
of the local authorities (Landesamt fu¨r Gesundheitsschutz,
Arbeitsschutz und Technische Sicherheit, Berlin, Germany, Project-
No.: G 0096/03).
Renal function
Serum and urine samples were collected in all groups. Creatinine
clearance was tested at monthly intervals and calculated as: urine
creatinine (mg/ml) urine volume (ml)/serum creatinine (mg/ml)
time of urine collection (min).
Protein excretion (mg/24 h) was measured by precipitation with
20% CCl3COOH. Turbidity was assessed at a wavelength of 415 nm
using a Hitachi 911 analyzer.
Proteinuria, the most sensitive parameter for chronic renal
allograft nephropathy in rat models,49 was tested at similar intervals.
The relative increase in urinary protein excretion between 1 and 6
months was calculated in recipients of grafts from older vs younger
donors and compared with the increase in protein excretion in age-
matched unilaterally nephrectomized controls.
Morphological analysis
Structural changes in allografts were compared with native kidneys in
age-matched uni-nephrectomized controls. Specimens were fixed in
4% buffered formalin, paraffin embedded, stained with hematoxylin
and eosin, and assessed by light microscopy. To determine the extent
of glomerulosclerosis, the number of glomeruli per kidney section
were counted and the ratio was expressed as a percentage of affected
to normal glomeruli. The extent of arteriosclerosis, cellular infiltrates,
tubular atrophy, and interstitial fibrosis was quantified on a 0 to 4þ
scale (4þ ¼ greatest structural deterioration / 420 fields of view per
section were evaluated at  200).
Flow cytometry
Heparinized blood and biopsies of spleen and graft sections were
obtained from LEW recipients at sequential time intervals. Graft
sections were pretreated with collagenase IV (1%/RPMI) for 30 min.
Peripheral blood mononuclear cells, splenocytes, and graft-infiltrat-
ing cells were isolated by a standard procedure using PancollTM
density gradient centrifugation (density 1.091 g/ml; Pan Biotech
GmbH, Aidenbach, Germany). After isolation, cells were resus-
pended in RPMI 1640 containing 10% fetal calf serum, 1%
glutamine, and 1% penicillin/streptomycin at a concentration of
5 106 cells/ml. Aliquots (400 ml) of the cell suspension were
distributed for staining.
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Mouse anti-rat mAbs (BD PharMingen GmbH, Heidelberg,
Germany; Biocarta Europe GmbH, Hamburg, Germany) used included
CD3-PE (IF4, T cells), CD4-APC (W3/25, T-helper cells), CD8-PerCP
(OX-8, cytotoxic T cells), Igk-fluorescein isothiocyanate (OX-12, Pan-
B cells), OX-62-PE (OX-62, rat DC), CD86-PE (24F, B7-2, activated B
cells, and monocytes), MHC class II-PerCP (OX-6, RT1B, activated
APC), and CD31-PE (TLD-3A12, platelet endothelial cellular adhesion
molecule/PECAM-1, leukocytes, and endothelial cells).
Fixed and stained lymphocyte samples were analyzed with a
FACScalibur, (Becton Dickinson, Palo Alto, CA) and analyzed with
CELLQuest software. The cytometer was calibrated with CaliBRITE1
beads (Becton Dickinson, USA) using FACSComp software and with
QC-3 beads according to the manufacturer’s recommendations
(Flow Cytometry Standards Corp., San Juan, Puerto Rico). A total of
500 000 events were acquired.
In vitro stimulation of rat splenocytes
Single cell suspensions of splenocytes were prepared in RPMI
medium with 10% fetal calf serum and dispensed into 24-well plates
at a concentration of 1 107/well. Cells were stimulated with
Lipopolysaccharide (LPS: 10 mg/ml), Concavalin A (ConA: 5 mg/ml)
for 5 h or phorbol 12-myristate 13-acetate (PMA 2 ng/ml)/
ionomycin (1mg/ml) for 24 h at 371C. Unstimulated rat spleen cells
served as controls. Supernatants of spleen cell cultures were tested
for IL-2, IFN-g, IL-4, and IL-10 using enzyme-linked immuno-
sorbent assay kits as recommended by the manufacturer (OptEIATM
Set, Pharmingen, San Diego, CA, USA).
Alloreactive ELISPOT
The frequency of alloreactive T cells was determined in LEW
recipients using a rat IFN-g ELISPOT assay (Diaclone, Besanc¸on
Cedex, France). Rat spleen cells were prepared as described above.
Briefly, polyvinylidine difluoride (PVDF)-bottomed 96-well micro-
titer plates (Diaclone) were incubated with 70% ethanol for 10 min.
Plates were incubated with an anti-rat IFN-g capture antibody for
12 h; unspecific binding was blocked with 2% skimmed dry milk in
phosphate-buffered saline. Subsequently, RPMI medium (negative
control), PMA (2 ng/ml/2 mg/ml, both Sigma Aldrich GmbH,
Munich, Germany), or 5 105 stimulator cells (F-344 splenocytes)
were dispensed into the wells. Thereafter, 5 105 responder cells
(LEW splenocytes) were added. Plates were incubated for 24 h,
washed and incubated with a biotinylated anti-rat IFN-g detection
antibody for 3 h. After a final 45 min incubation period with a
streptavidin-alkaline phosphatase conjugate and subsequent admin-
istration of the staining buffer (BCTP/NTB; Diaclone), plates were
dried and alloreactive T cells were measured using the BIOREA-
DERs 3000 C/BIOCOUNTER system (BIOREADER 3000 C, BIO-
SYS GmbH, Karben, Germany). The actual frequency was
determined as a ratio of the number of spots/number of responder
cells. This ratio was then adapted to the actual percentage of T cells
in the responder cell preparation assessed by flow cytometry.50
Statistics
Data were expressed as mean7s.e. for comparison using unpaired
t-test or Mann–Whitney Test, respectively. Statistical difference was
accepted at Po0.05.
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